The Challenge:
A leading healthcare brand wanted to validate the performance of its new daytime over the counter (OTC) product against top competitors to substantiate future on-pack and marketing claims.
The goal was to generate robust, independent evidence on taste and overall product experience, while identifying opportunities for refinement based on consumer feedback.
The Solution:
We ran a controlled sequential monadic central location test (CLT) across multiple US cities, engaging 600 adults in blind tastings of leading cold and flu tablets.
Participants assessed taste, texture, aroma, aftertaste, and overall enjoyment before selecting their preferred option. Short IDIs explored the drivers of preference and clarified claim territories. All findings were analysed at a 95 percent confidence level to generate defensible evidence for future claim use.
The Result:
The research provided strong, statistically validated proof of product superiority, enabling the brand to activate best-tasting claims with confidence. The evidence supported new advertising and retail communications launched across major US retailers and online platforms within weeks.
These insights strengthened the brand’s credibility, informed product refinement, and established a scalable framework for future claims testing, ensuring the brand remains competitive within the growing cold and flu category.
Get in touch to explore how we can help you turn consumer understanding into competitive advantage. Contact [email protected] to discuss your needs.





Stay In Touch